87 related articles for article (PubMed ID: 3186719)
1. Cancer antigens are expressed in a carcinogen-transformed Bloom syndrome B-lymphoblastoid cell line.
Shiraishi Y; Soma H
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8211-5. PubMed ID: 3186719
[TBL] [Abstract][Full Text] [Related]
2. Characteristic mucinous ovarian cancer antigen is expressed in malignantly transformed Bloom's syndrome cells.
Shiraishi Y; Yamamoto K; Soma H
Cancer Res; 1993 Jul; 53(14):3427-32. PubMed ID: 8391927
[TBL] [Abstract][Full Text] [Related]
3. Malignant lymphoma antigen expressed in nude mouse tumor cells derived from carcinogen-transformed Bloom's syndrome B-lymphoblastoid cell lines.
Shiraishi Y; Moriki T; Hara H; Araki K; Kozuru M; Sandberg AA
Cancer Res; 1990 May; 50(10):3106-12. PubMed ID: 2185881
[TBL] [Abstract][Full Text] [Related]
4. Panning and immune electron-microscopic study of mucinous ovarian-cancer antigen-specific cells derived from malignantly transformed bloom-syndrome B-lymphoblastoid cells.
Shiraishi Y; Ozawa M; Yamamoto K; Yagyu K; Nakayama K; Sagara Y; Takakusu A
Int J Oncol; 1994 Jun; 4(6):1183-9. PubMed ID: 21567035
[TBL] [Abstract][Full Text] [Related]
5. Expression of mucinous ovarian-cancer antigen in hybrid-cells derived by fusing a malignantly transformed bloom-syndrome cell-line (bs-shi-4m ovc-mu) and mouse L-cell-line.
Shiraishi Y; Taguchi T; Seguchi H
Int J Oncol; 1995 Dec; 7(6):1275-8. PubMed ID: 21552960
[TBL] [Abstract][Full Text] [Related]
6. Western blotting analysis for malignant lymphoma and stomach cancer antigens from carcinogen-transformed Bloom syndrome cells.
Shiraishi Y
Int J Cancer; 1990 Apr; 45(4):783-7. PubMed ID: 2323853
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of stomach cancer antigen derived from malignantly transformed bloom syndrome cells previously labeled with bromodeoxyuridine.
Shiraishi Y; Ogata T; Soma H
Cancer Genet Cytogenet; 1992 Aug; 62(1):1-8. PubMed ID: 1521223
[TBL] [Abstract][Full Text] [Related]
8. MNNG-transformed Bloom syndrome B-lymphoblastoids for the detection of Hodgkin's lymphoma-associated antigen in 2D Westerns.
Bhalla A; Bamezai R
Cancer Lett; 1998 Apr; 126(1):7-15. PubMed ID: 9563642
[TBL] [Abstract][Full Text] [Related]
9. Interaction of bloom-syndrome cellular cancer antigens with sera of malignant-lymphoma patients - an immunological and cytogenetical study.
Shiraishi Y
Int J Oncol; 1994 Mar; 4(3):533-41. PubMed ID: 21566955
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of Bloom syndrome B-lymphoblastoid cell lines by carcinogens.
Shiraishi Y; Yosida TH; Sandberg AA
Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5102-6. PubMed ID: 3875094
[TBL] [Abstract][Full Text] [Related]
11. T-cell receptor-gamma rearrangement and c-myb methylation in MNNG-exposed Bloom syndrome B-lymphoblastoid cells.
Bhalla A; Sachdeva G; Bamezai R
Cancer Lett; 1998 Apr; 126(1):1-6. PubMed ID: 9563641
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic relevance of abortion-associated human embryonic antigen expressed on the cell surface of tumour promoter-treated Bloom syndrome cells.
Shiraishi Y; Shiraishi Y; Yamamoto D; Hasegawa T; Kitamura W; Miki S; Tanaka T; Suzuki T; Soma H
Hum Reprod; 1995 Jul; 10(7):1694-701. PubMed ID: 8582963
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient.
Roncella S; Di Celle PF; Cutrona G; Carbone A; Sessarego M; Landonio G; Foà R; Rowe M; Ferrarini M
Leuk Lymphoma; 1993 Jan; 9(1-2):157-64. PubMed ID: 8386576
[TBL] [Abstract][Full Text] [Related]
14. HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones.
Huarte E; Karbach J; Gnjatic S; Bender A; Jäger D; Arand M; Atanackovic D; Skipper J; Ritter G; Chen YT; Old LJ; Knuth A; Jäger E
Cancer Immun; 2004 Dec; 4():15. PubMed ID: 15600300
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells.
Ioannides CG; Freedman RS; Platsoucas CD; Rashed S; Kim YP
J Immunol; 1991 Mar; 146(5):1700-7. PubMed ID: 1704404
[TBL] [Abstract][Full Text] [Related]
16. Large deletions at the HPRT locus associated with the mutator phenotype in a Bloom's syndrome lymphoblastoid cell line.
Tachibana A; Tatsumi K; Masui T; Kato T
Mol Carcinog; 1996 Sep; 17(1):41-7. PubMed ID: 8876674
[TBL] [Abstract][Full Text] [Related]
17. A new human T-cell lymphoma cell line (Karpas 384) of the T-cell receptor gamma/delta lineage with translocation t(7:14) (p13;q11.2).
Dyer MJ; Nacheva E; Fischer P; Heward JM; Labastide W; Karpas A
Leukemia; 1993 Jul; 7(7):1047-53. PubMed ID: 8391614
[TBL] [Abstract][Full Text] [Related]
18. Effects of mutagens on the immunogenicity of murine tumor cells: immunological and biochemical evidence for altered cell surface antigens.
Altevogt P; von Hoegen P; Leidig S; Schirrmacher V
Cancer Res; 1985 Sep; 45(9):4270-7. PubMed ID: 4028013
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in cell lines and lymphoma originating from Bloom syndrome.
Kaneko H; Morimoto W; Fukao T; Kasahara K; Kondo N
Leuk Lymphoma; 2001 Aug; 42(4):757-60. PubMed ID: 11697506
[TBL] [Abstract][Full Text] [Related]
20. Dimorphism of sister chromatid exchange in Bloom's syndrome B- and T-cell lines transformed with Epstein-Barr and adult T-cell leukemia viruses.
Shiraishi Y; Yoshimoto S; Miyoshi I; Kondo N; Orii T; Sandberg AA
Cancer Res; 1983 Aug; 43(8):3836-40. PubMed ID: 6305496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
